TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET Â | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET Â | Source: Cerevance, Inc. Phase 2 results…
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 05, 2025 17:00 ET Â | Source: Rocket Doctor AI Inc. Vancouver,…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2025 08:00 ET Â | Source: UroGen Pharma Ltd. PRINCETON, N.J.,…
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET Â | Source: Amneal Pharmaceuticals LLC Interim data…
Carl H. Sharperson III Joins MATTER Board of Directors
December 03, 2025 10:00 ET Â | Source: MATTER MINNEAPOLIS, MN , Dec.…
Cribl Supercharges Incident Response in Amazon Security Hub with Open Cybersecurity Schema Framework (OCSF) Support
Enhanced capability in Cribl Stream transforms disparate security findings into a standardized…
PDF Solutions to Make Its Analyst Day Webcast and Presentation Available
Company Also Reaffirms 2025 Financial Outlook December 01, 2025 19:01 ET  |…
TAP Sleep Care Secures Full Medicare Portfolio Coverage: Nylon flexTAP Receives PDAC Approval under E0486
December 01, 2025 12:10 ET Â | Source: Airway Management, Inc. DALLAS, Dec.…